Drafting a Medical Team Going through cancer treatment and ensuing complications is never easy, but surrounding yourself with the right key players can help, writes pancreatic cancer survivor Rob Weker. by Rob Weker Worth the Wait Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients. by Sharon Tregaskis Tumor Testing May Help Guide Pancreatic Cancer Treatment For a small group of pancreatic cancer patients who were able to receive therapies targeting the molecular alterations in their tumors, these matched therapies were associated with longer life. by Cheryl Platzman Weinstock Forward Look More Options to Prevent Blood Clots in High-Risk Cancer Patients Updated guidelines support use of oral blood thinners. by Jane Langille FORWARD LOOK New Guidelines for Radiation Therapy in Pancreatic Cancer Recommendations address conflicts and research gaps. by Ashley P. Taylor The Puzzle of Pancreatic Cancer Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend. by Kendall K. Morgan Turning Up the Heat on Cancer Researchers are working to expand the benefits of immunotherapy by making “cold” tumors “hot” so they can respond better to treatments. by Kendall K. Morgan PARP Inhibitors in Pancreatic Cancer Drugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer. by Kate Yandell Some Pancreatic Cancers Are Hereditary A trio of recent studies indicates that pancreatic cancer is, in some cases, linked to mutations passed down from generation to generation. by Cheryl Platzman Weinstock Yesterday & Today TV’s Family Man Michael Landon, best known for his roles on Little House on the Prairie and Bonanza, created and starred in programs that portrayed family values with authenticity and humor. by Marci A. Landsmann next Cancer Talk Drug Delays Recurrence in People With Early-Stage Breast Cancer People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor. by Pamela Rafalow Grossman Open Medical Records: Pros and Cons Patients now have full access to their online medical records. What are the benefits and downsides? by Jen Tota McGivney Remote Care After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment. by Jon Kelvey Moving Away From the Maximum Tolerated Dose The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate. by Marcus A. Banks More Posts